Filing Details
- Accession Number:
- 0001179110-21-010113
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-15 16:26:31
- Reporting Period:
- 2021-11-12
- Accepted Time:
- 2021-11-15 16:26:31
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1650664 | Editas Medicine Inc. | EDIT | Biological Products, (No Disgnostic Substances) (2836) | 464097528 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1830610 | Anne Lisa Michaels | C/O Editas Medicine, Inc. 11 Hurley St. Cambridge MA 02141 | Evp/Chief Medical Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-11-12 | 1,568 | $38.33 | 18,432 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on November 11, 2021, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on November 9, 2021. The sale does not represent a discretionary trade by the Reporting Person.